Dermskin s.r.o.
- Address
- Janskeho 463/24, 779 00 Povel, Czechia
Dermskin s.r.o. - Plaque Psoriasis Research Center
Dermskin s.r.o. is a specialized dermatological research center dedicated to advancing treatment options for patients with moderate to severe plaque psoriasis. The center focuses exclusively on evaluating novel therapeutic interventions, participating in pivotal Phase 3 clinical trials that assess both short-term efficacy and long-term safety profiles of emerging systemic treatments.
- Long-term safety and tolerability studies of oral and systemic psoriasis therapies
- Comparative efficacy trials of novel investigational agents versus active comparators
- Extension studies evaluating durability of response in chronic plaque psoriasis
- Phase 3 registration trials for next-generation oral immunomodulatory agents
The research center maintains particular expertise in evaluating oral once-daily therapies including tyrosine kinase 2 (TYK2) inhibitors and Janus kinase (JAK) inhibitors. With extensive experience in open-label extension protocols, Dermskin s.r.o. contributes valuable data on the long-term management of moderate-to-severe psoriasis, helping to establish the sustained safety and efficacy profiles essential for regulatory approval and clinical practice implementation of innovative dermatological treatments.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dermskin s.r.o.
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Plaque Psoriasis | Bristol-Myers Squibb Services Unlimited Company | Phase III | Not Recruiting | Dec 2019 | Jul 2025 |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Zasocitinib | 3 | Unknown | 2024-05-07 | 2025-09-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.